Showing 37,981 - 38,000 results of 101,127 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( 5 ((nm decrease) OR (teer decrease)) ))', query time: 1.67s Refine Results
  1. 37981

    Supplementary file 4_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  2. 37982

    Data Sheet 4_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  3. 37983

    Supplementary file 1_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  4. 37984

    Supplementary file 2_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  5. 37985

    Supplementary file 3_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  6. 37986

    Data Sheet 3_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  7. 37987

    Data Sheet 1_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  8. 37988

    Data Sheet 2_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

    Published 2025
    “…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”
  9. 37989

    Supplementary Material for: Effects of a DPP4 Inhibitor on Progression of NASH-related HCC and the p62/ Keap1/Nrf2-Pentose Phosphate Pathway in a Mouse Model by Kawaguchi T. (5713799)

    Published 2018
    “…Metabolome analysis revealed that DPP4i significantly increased 6-phosphogluconic acid and ribose 5-phosphate levels and decreased the AMP-to-adenine and GMP-to-guanine ratios (AMP-to-adenine ratio 0.7 ± 0.2 vs. 2.0 ± 1.2, <i>p</i> < 0.01; GMP-to-guanine ratio 0.6 ± 0.3 vs. 1.5 ± 0.7, <i>p</i> < 0.01). …”
  10. 37990

    DataSheet_1_Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.docx by Jackwee Lim (218815)

    Published 2021
    “…Strikingly, survivors of severe COVID-19 had decreased proportions of NKT and Vδ2 T cells, and increased proportions of low-density neutrophils, IgA+/CD86+/CD123+ non-classical monocytes and hyperactivated HLADR+CD38+ CD8+ T cells, and elevated levels of pro-inflammatory cytokines such as hepatocyte growth factor and vascular endothelial growth factor A, long after virus clearance. …”
  11. 37991

    A DNA nanodevice for mapping sodium at single organelle resolution - raw data by Junyi Zou (16821438)

    Published 2023
    “…By measuring Na<sup>+</sup> at single endosome resolution in mammalian cells and in <i>C. elegans</i>, we discover that lumenal<i> </i>Na<sup>+</sup> levels in each stage of the endolysosomal pathway exceed cytosolic levels and decrease as endosomes mature. Further, we find that lysosomal Na<sup>+</sup> levels in nematodes are modulated by the Na<sup>+</sup>/H<sup>+</sup> exchanger NHX-5 in response to salt stress. …”
  12. 37992

    Schistosoma mansoni associated glomerulopathy with IgA mesangial deposits: case report by Fabiana Oliveira Gonçalves (10467328)

    Published 2021
    “…Method: It was reported a case of a 36 years old patient, brown, with classical sintoms of nephrotic syndrome (proteinuria > 3.5 g/24h, hypoalbuminemia and hypercholesterolemia), however with hepatosplenic schistosomiasis history 7 years ago and portal hypertension. …”
  13. 37993

    Length Scale of the Dendritic Array Tailoring Strength of a 5052 Aluminum Alloy by Cínthia Toshimi Ogata (6046400)

    Published 2018
    “…The 5052 alloys containing higher Mg content may induce a decrease in λ2 for a certain growth velocity. …”
  14. 37994

    Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis by Nathan R. Hill (802856)

    Published 2016
    “…Global mean(95%CI) CKD prevalence of 5 stages 13·4%(11·7–15·1%), and stages 3–5 was 10·6%(9·2–12·2%). …”
  15. 37995
  16. 37996

    Data_Sheet_1_Efficacy and feasibility of a 12-week Tai Chi training for the prophylaxis of episodic migraine in Hong Kong Chinese women: A randomized controlled trial.docx by Yao Jie Xie (10073843)

    Published 2022
    “…Women aged 18 to 65 years and diagnosed with episodic migraine were randomized to either Tai Chi group (TC group) or the waiting list control group. A modified 33-short form Yang-style Tai Chi training with 1 h per day, 5 days per week for 12 weeks was implemented in the TC group, with a 12-week follow up period. …”
  17. 37997

    <i>In vivo</i> effect of NIR-PIT for MDAMB231 tumor. by Tadanobu Nagaya (789144)

    Published 2015
    “…The tumor treated by NIR-PIT showed decreasing IR700 fluorescence after NIR-PIT. (C) Tumor growth was significantly inhibited in the PIT treatment groups with cet-IR700 (n = 10–13, *<i>p</i> < 0.05 vs i.v. group, **<i>p</i> < 0.01 vs control and light only group, Bonferroni’s test with ANOVA). …”
  18. 37998

    DMOG treatment affects worm body morphology in a dose-dependent manner. by Megan M. Braun (8201181)

    Published 2019
    “…Measurements were normalized to untreated worm measurements. A Dunnett’s test was used to compare mean morphological characteristics of DMOG-treated to untreated worms. …”
  19. 37999

    <i>In vivo</i> effect of NIR-PIT for MDAMB468 tumor (one shot NIR-PIT). by Tadanobu Nagaya (789144)

    Published 2015
    “…<p>(A) NIR-PIT regimen. Fluorescence images were obtained at each time point as indicated. …”
  20. 38000